IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance

被引:58
作者
Maddux, Betty A.
Chan, Adelene
Mandarino, Lawrence J.
Goldfine, Ira D.
机构
[1] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA
[2] Arizona State Univ, Sch Life Sci, Tempe, AZ USA
关键词
D O I
10.2337/dc05-1367
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - IGF-binding protein (IGFBP)-1 is negatively regulated by insulin. We determined Whether the measurement of IGFBP-1 in serum is a useful marker of insulin resistance. RESEARCH DESIGN AND METHODS - Twenty-three subjects underwent a euglycemic insulin clamp. Glucose disposal rates (M) were then correlated with measurements of IGFBP-1, fasting insulin levels, homeostasis model assessment (HOMA), and BMI. RESULTS- IGFBP-1 levels more strongly correlated with M (R =.0.73) than the other parameters such as BMI or HOMA. The level of this protein decreased in individuals who became more insulin sensitive by exercise training. CONCLUSIONS - These studies show a strong correlation between insulin sensitivity and the serum levels of IGFBP-1. These studies suggest, therefore, that measurement of this protein may be valuable in identifying those individuals with insulin resistance and those individuals who respond to interventional strategies.
引用
收藏
页码:1535 / 1537
页数:3
相关论文
共 15 条
[1]   Ceramide content is increased in skeletal muscle from obese insulin-resistant humans [J].
Adams, JM ;
Pratipanawatr, T ;
Berria, R ;
Wang, E ;
DeFronzo, RA ;
Sullards, MC ;
Mandarino, LJ .
DIABETES, 2004, 53 (01) :25-31
[2]   Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[3]   Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle [J].
Cusi, K ;
Maezono, K ;
Osman, A ;
Pendergrass, M ;
Patti, ME ;
Pratipanawatr, T ;
DeFronzo, RA ;
Kahn, CR ;
Mandarino, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) :311-320
[4]   Pathogenesis of type 2 diabetes mellitus [J].
DeFronzo, RA .
MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (04) :787-+
[5]   Cellular actions of the insulin-like growth factor binding proteins [J].
Firth, SM ;
Baxter, RC .
ENDOCRINE REVIEWS, 2002, 23 (06) :824-854
[6]   Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations [J].
Heald, AH ;
Cruickshank, JK ;
Riste, LK ;
Cade, JE ;
Anderson, S ;
Greenhalgh, A ;
Sampayo, J ;
Taylor, W ;
Fraser, W ;
White, A ;
Gibson, JM .
DIABETOLOGIA, 2001, 44 (03) :333-339
[7]  
LEE PDK, 1993, P SOC EXP BIOL MED, V204, P4
[8]   Insulin-like growth factor binding protein-1 is independently affected by ethnicity, insulin sensitivity, and leptin in healthy, glucose-tolerant young men [J].
Liew, CF ;
Wise, SD ;
Yeo, KP ;
Lee, KO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1483-1488
[9]   Insulin sensitivity indices obtained from oral glucose tolerance testing - Comparison with the euglycemic insulin clamp [J].
Matsuda, M ;
DeFronzo, RA .
DIABETES CARE, 1999, 22 (09) :1462-1470
[10]   Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals [J].
McLaughlin, T ;
Allison, G ;
Abbasi, F ;
Lamendola, C ;
Reaven, G .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (04) :495-499